Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30M Buy
119,340
+13,419
+13% +$2.89M 1.1% 25
2026
Q1
$23M Buy
105,921
+4,662
+5% +$1.03M 1.18% 24
2025
Q4
$23.1M Buy
101,259
+75,595
+295% +$17.2M 1.76% 17
2025
Q3
$5.94M Buy
25,664
+21,932
+588% +$4.47M 0.51% 27
2025
Q2
$693K Buy
3,732
+177
+5% +$32.9K 0.07% 58
2025
Q1
$745K Buy
3,555
+812
+30% +$158K 0.09% 53
2024
Q4
$487K Buy
2,743
+349
+15% +$64.2K 0.06% 94
2024
Q3
$473K Sell
2,394
-109
-4% -$20.3K 0.06% 77
2024
Q2
$429K Sell
2,503
-15
-0.6% -$2.48K 0.06% 75
2024
Q1
$459K Buy
2,518
+226
+10% +$38.9K 0.1% 73
2023
Q4
$355K Buy
+2,292
New +$334K 0.2% 88

Other funds holding ABBV

Global X Japan's ABBV Position: Q2 2026 in Review

Global X Japan increased its AbbVie (ABBV) stake by 13% in Q2 2026, buying an estimated $2.89M and bringing the position to 119,340 shares worth $30M. The position accounts for 1.1% of the portfolio, ranked #25.

Global X Japan first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Global X Japan held 119,340 shares of AbbVie worth $30M as of Q2 2026.
  • Global X Japan bought 13,419 AbbVie shares in Q2 2026, an estimated $2.89M.
  • AbbVie made up 1.1% of Global X Japan's portfolio in Q2 2026, its #25 holding.
  • Global X Japan first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Global X Japan's 13F filing for Q2 2026, filed 14 Jul 2026.